Literature DB >> 33748490

Study of microbiome changes in patients with ulcerative colitis in the Central European part of Russia.

M V Gryaznova1,2, S A Solodskikh1,2, A V Panevina1, M Y Syromyatnikov1,2, Yu D Dvoretskaya1,2, T N Sviridova3,4, E S Popov2, V N Popov1,2.   

Abstract

Ulcerative colitis (UC) is an inflammatory disease that affects the colon and rectum. Recently, evidence has emerged about the influence of microbiota on the development of this disease. However, studies on the role of intestinal microbiota in the pathogenesis of UC have been incomplete. In addition, there are no comprehensive studies of the causes of ulcerative colitis and data on the microbiological composition of the intestines of patients with ulcerative colitis in Russia. We carried out a study of the microbiological composition of the intestines of patients with ulcerative colitis and healthy individuals. We found significant changes in the bacteria genera and species in patients with UC compared with the control group using sequencing on the IonTorrent PGM system and subsequent data analysis. In our study we observed a significant increase of the genus Haemophilus, Olsenella, Prevotella, Cedecea, Peptostreptococcus, Faecalibacterium, Lachnospira, Negativibacillus, Butyrivibrio, and the species Bacteroides coprocola, Phascolarctobacterium succinatutens, Dialister succinatiphilus, Sutterella wadsworthensis, Faecalibacterium prausnitzii in patients with ulcerative colitis. In addition, in patients with ulcerative colitis there was a significant decrease in the genus Fusicatenibacter, Butyricimonas, Lactococcus, Eisenbergiella, Coprobacter, Cutibacterium, Falsochrobactrum, Brevundimonas, Yersinia, Leuconostoc and in the species Fusicatenibacter saccharivorans. We found confirmation of our data with literary sources and studies of UC. In addition, we discovered a few taxa such as Negativibacillus spp. and Falsochrobactrum spp. that have not been previously found in human stool samples. Our data confirm that more research is needed to understand the role of microbiome changes in the development of UC in different people populations.
© 2021 The Authors.

Entities:  

Keywords:  Inflammatory bowel disease; Intestinal microbiota; Russian population; Sequencing; Ulcerative colitis

Year:  2021        PMID: 33748490      PMCID: PMC7970149          DOI: 10.1016/j.heliyon.2021.e06432

Source DB:  PubMed          Journal:  Heliyon        ISSN: 2405-8440


  5 in total

1.  Resistant Maltodextrin Consumption in a Double-Blind, Randomized, Crossover Clinical Trial Induces Specific Changes in Potentially Beneficial Gut Bacteria.

Authors:  Volker Mai; Alyssa M Burns; Rebecca J Solch; Jennifer C Dennis-Wall; Maria Ukhanova; Bobbi Langkamp-Henken
Journal:  Nutrients       Date:  2022-05-25       Impact factor: 6.706

2.  Interactions between Human Gut Microbiome Dynamics and Sub-Optimal Health Symptoms during Seafaring Expeditions.

Authors:  Zheng Sun; Meng Zhang; Min Li; Yogendra Bhaskar; Jinshan Zhao; Youran Ji; Hongbing Cui; Heping Zhang; Zhihong Sun
Journal:  Microbiol Spectr       Date:  2022-01-12

3.  Effects of Xylo-Oligosaccharide on the Gut Microbiota of Patients With Ulcerative Colitis in Clinical Remission.

Authors:  Zongwei Li; Zhengpeng Li; Liying Zhu; Ning Dai; Gang Sun; Lihua Peng; Xin Wang; Yunsheng Yang
Journal:  Front Nutr       Date:  2021-12-28

4.  Crocetin Prolongs Recovery Period of DSS-Induced Colitis via Altering Intestinal Microbiome and Increasing Intestinal Permeability.

Authors:  Peishi Feng; Qiaoqiao Li; Ling Liu; Siyu Wang; Zhipeng Wu; Yi Tao; Pan Huang; Ping Wang
Journal:  Int J Mol Sci       Date:  2022-03-30       Impact factor: 5.923

5.  Gut microbiota in systemic lupus erythematosus patients and lupus mouse model: a cross species comparative analysis for biomarker discovery.

Authors:  Eya Toumi; Benoit Goutorbe; Anne Plauzolles; Marion Bonnet; Soraya Mezouar; Muriel Militello; Jean-Louis Mege; Laurent Chiche; Philippe Halfon
Journal:  Front Immunol       Date:  2022-08-02       Impact factor: 8.786

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.